Do cancer centres and palliative care wards routinely measure patients’ quality of life? An international cross-sectional survey study

• Published in: Supportive care in cancer Vol. 31; no. 8; p. 499
• Main Authors: Miranda, Rose, Raemdonck, Eveline, Deliens, Luc, Kaasa, Stein, Zimmermann, Camilla, Rodin, Gary, Robijn, Lenzo, Lundeby, Tonje, Houbracken, Isabelle, Beernaert, Kim
• Format: Journal Article
• Language: English; Norwegian
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2023; Springer; Springer Nature B.V
• Subjects: Cancer; Cancer patients; Cross-sectional studies; Medical informatics; Medical research; Medical screening; Medicine; Medicine & Public Health; Medicine, Experimental; Nursing; Nursing Research; Oncology; Pain Medicine; Palliative care; Palliative treatment; Patients; Polls & surveys; Quality of life; Rehabilitation Medicine; Palliative care; Patient-reported outcome measures; Quality of life; Cancer
• ISSN: 0941-4355; 1433-7339
• DOI: 10.1007/s00520-023-07964-4

Purpose Routinely assessing quality of life (QoL) of patients with cancer is crucial for improving patient-centred cancer care. However, little is known about whether or how cancer centres assess QoL for clinical practice or for research purposes. Therefore, our study aimed to investigate if QoL data is collected and if so, how and for what purposes. Method We conducted a cross-sectional survey study among 32 cancer centres in Europe and Canada. Centre representatives identified persons who they judged to have sufficient insight into QoL data collections in their wards to complete the survey. Descriptive statistics were used to summarise the information on QoL assessment and documentation. Results There were 20 (62.5%) responding cancer centres. In total, 30 questionnaires were completed, of which 13 were completed for cancer wards and 17 for palliative care wards. We found that 23.1% and 38.5% of the cancer wards routinely assessed QoL among inpatients and outpatients with cancer, respectively, whereas, in palliative care wards, 52.9% assessed QoL for outpatients with cancer and 70.6% for the inpatients. Wide variabilities were observed between the cancer centres in how, how often, when and which instruments they used to assess QoL. Conclusion A sizable proportion of the cancer wards, especially, and palliative care wards apparently does not routinely assess patients’ QoL, and we found wide variabilities between the cancer centres in how they do it. To promote routine assessment of patients’ QoL, we proposed several actions, such as addressing barriers to implementing patient-reported outcome measures through innovative e-health platforms.